Consumer wearables have quietly become one of the most significant shifts in personal health monitoring in a generation. Devices that were once step counters are now measuring cardiac electrical activity, estimating aerobic capacity, and tracking nervous system recovery with enough precision to be clinically useful in some contexts. For anyone focused on healthspan, this represents a genuine opportunity but only if you understand what each metric actually measures, what it can and cannot tell you, and how to act on it without either ignoring meaningful signals or over-interpreting noise.
This article covers the three metrics with the strongest evidence base for healthspan relevance: heart rate variability (HRV), VO2 max, and single-lead ECG. Each measures something distinct, serves a different purpose, and requires a different approach to interpretation.
Heart Rate Variability (HRV): Your Recovery and Resilience Indicator
Heart rate variability is the variation in time between consecutive heartbeats, measured in milliseconds. A common misconception is that a healthy heart beats like a metronome in fact, healthy cardiac function produces significant beat-to-beat variation driven by the constant interplay between the sympathetic (activating) and parasympathetic (calming) branches of your autonomic nervous system. Higher HRV reflects a nervous system that can fluidly shift between these states a marker of physiological flexibility and recovery capacity. Lower HRV indicates sympathetic dominance, reduced adaptability, and accumulated physiological stress.
HRV is measured overnight by most wearables including Oura Ring, Garmin devices, Apple Watch (Series 4 and later), and Whoop using photoplethysmography (PPG), which detects blood volume changes through the skin. Overnight measurement captures a stable baseline uncontaminated by activity, posture, or acute stress, making it the most reliable window for tracking trends across days and weeks.
HRV is most useful as a trend metric rather than a single day snapshot. A consistently high HRV relative to your personal baseline suggests good recovery, low allostatic load, and readiness for physical and cognitive demand. A declining trend across days signals accumulated stress from training load, poor sleep, illness, alcohol, emotional demands, or any combination of these and is a reliable cue to prioritise recovery before adding further challenge. HRV does not diagnose specific conditions, but it reflects the aggregate state of your nervous system in a way that no single other consumer metric currently matches.
Population reference ranges for HRV vary enormously by age, fitness, and individual physiology comparison to published averages is less useful than tracking your own baseline over time. Most wearable platforms calculate a rolling 30 to 90-day average and flag deviations from your personal norm, which is the clinically appropriate approach. A reading 20% or more below your personal baseline is generally worth taking seriously as a signal to reduce load that day.
Higher resting HRV is independently associated with lower all cause mortality, reduced cardiovascular disease risk, better cognitive function, and improved stress resilience in large prospective studies. A 2023 meta-analysis in the Journal of the American Heart Association confirmed HRV as a significant predictor of cardiovascular outcomes independent of traditional risk factors. For healthspan purposes, consistent HRV monitoring provides an objective window into how well your daily habits sleep, nutrition, movement, stress management are actually landing on your physiology.
VO2 Max: The Single Strongest Predictor of Long-Term Health
VO2 max is your body's maximum rate of oxygen consumption during intense exercise the upper ceiling of your aerobic system. It is measured in millilitres of oxygen per kilogram of body weight per minute (ml/kg/min) and reflects the integrated efficiency of your cardiovascular system, lungs, blood oxygen-carrying capacity, and muscle mitochondrial density. It is, in straightforward terms, a measure of how powerful your aerobic engine is.
What makes VO2 max exceptional from a healthspan perspective is the consistency and strength of its relationship with long-term outcomes. A landmark 2018 study in JAMA Network Open following over 120,000 patients found that low cardiorespiratory fitness as measured by VO2 max was a stronger predictor of all-cause mortality than smoking, hypertension, diabetes, or high cholesterol. Each 3.5 ml/kg/min increase in VO2 max was associated with a 13% reduction in all-cause mortality. No other single biomarker in consumer health tracking approaches this predictive power.
VO2 max is the closest thing to a single number that predicts how long and how well you will live. If you track only one metric for long term healthspan, this is the one and it is directly trainable at any age.
Consumer wearables estimate VO2 max algorithmically from heart rate response during exercise comparing heart rate to speed or power output and modelling aerobic efficiency from that relationship. Apple Watch, Garmin, Polar, and Fitbit all provide VO2 max estimates. These estimates carry meaningful error margins (typically plus or minus 5 to 10%) compared to laboratory testing, but they are directionally useful and track changes in fitness reliably over months of training.
These are approximate values for general health context not athletic performance targets. Values in ml/kg/min. Men aged 30 to 39: poor below 35, good 42 to 49, excellent above 53. Men aged 40 to 49: poor below 33, good 40 to 47, excellent above 51. Women aged 30 to 39: poor below 29, good 35 to 42, excellent above 45. Women aged 40 to 49: poor below 27, good 33 to 39, excellent above 43. VO2 max declines approximately 1% per year from age 25 without intervention but regular aerobic training consistently attenuates this decline, and improvements are achievable at any age.
VO2 max responds most powerfully to high-intensity interval training (HIIT) and zone 2 aerobic training (conversational pace steady state exercise). Current evidence suggests a combination of both produces the best results: 2 to 3 sessions of zone 2 per week (30 to 60 minutes each) plus 1 to 2 HIIT sessions (4 to 6 intervals of 3 to 4 minutes at near-maximal effort). Meaningful improvement in VO2 max is typically visible within 6 to 12 weeks of consistent training.
Single-Lead ECG: Detecting What the Others Cannot
The ECG (electrocardiogram) function available on Apple Watch (Series 4 and later), Samsung Galaxy Watch (Series 4 and later), and Withings ScanWatch records the electrical activity of the heart as a waveform. Unlike HRV and VO2 max, which are performance and wellness metrics, the smartwatch ECG is a diagnostic tool its primary purpose is detecting atrial fibrillation (AF), the most common cardiac arrhythmia and a major risk factor for stroke.
The Apple Watch ECG algorithm has been validated in multiple peer reviewed studies and is TGA-cleared in Australia for AF detection. In the Apple Heart Study the largest digital health study to date the passive AF detection feature identified irregular pulse in 0.5% of over 400,000 participants, with 84% of those subsequently confirmed as AF on clinical ECG. Sensitivity and specificity for AF detection in consumer studies are generally in the range of 98% and 99% respectively comparable to clinical single-lead ECG in rhythm assessment.
Can detect: atrial fibrillation, sinus rhythm, high or low heart rate. Cannot detect: heart attack (requires multi-lead ECG and biomarkers), structural heart disease, coronary artery disease, ventricular arrhythmias, or most other cardiac conditions. A normal smartwatch ECG reading does not rule out heart disease it rules out AF during that recording only. A positive AF reading warrants prompt follow-up with your GP, not self-management.
AF is particularly relevant in the Australian healthspan context. Prevalence increases sharply with age affecting approximately 1% of adults under 60 and rising to 10 to 15% in those over 80. It is frequently asymptomatic, meaning many people have it without knowing. AF raises stroke risk fivefold, but when detected and treated — typically with anticoagulation that risk is substantially reduced. Opportunistic detection through a wearable ECG represents a genuine screening benefit for older Australians who would not otherwise have had the rhythm assessed.
How to Use All Three Together
Each metric serves a different time horizon and purpose, and they work best understood as complementary rather than competitive.
HRV is your daily readiness signal use it to calibrate how hard to push on any given day, whether your recovery practices are working, and when accumulated stress is exceeding your recovery capacity. It is the metric most directly actionable in the short term.
VO2 max is your long-term healthspan trajectory use it to track whether your aerobic fitness is improving, maintaining, or declining over months and years. It is the metric most strongly linked to longevity outcomes and most responsive to training intervention. Check it monthly rather than daily.
ECG is your safety net for arrhythmia use it when you notice palpitations, irregular heartbeat sensations, unexplained breathlessness, or dizziness and share concerning recordings with your GP. Do not use it to self-diagnose or self-manage.
Track HRV as a 30-day trend, not a daily number. Review VO2 max monthly and use it to guide your training approach. Run an ECG if you feel symptoms, and take any AF alert to your GP promptly. Avoid the trap of checking metrics obsessively data is useful when it informs decisions, not when it generates anxiety. If your wearable data is causing more stress than insight, that is a signal to reduce your monitoring frequency, not increase it.
Limitations Worth Knowing
Consumer wearables are not medical-grade devices. PPG-based HRV and VO2 max estimates carry algorithmic error that varies by device, skin tone, wrist placement, movement, and ambient conditions. Dark skin tones have historically been associated with reduced PPG accuracy a known limitation that device manufacturers are actively working to address in newer hardware generations. VO2 max estimates are most accurate when calibrated through outdoor running with GPS rather than indoor or low-speed activity.
Wearable ECG recordings are subject to motion artefact and require the user to remain still during the 30-second recording window. A poor quality recording labelled "inconclusive" should be repeated, not interpreted. Any ECG feature flagged as AF by a consumer device should be followed up with a clinical assessment it is a prompt to see your doctor, not a diagnosis in itself.
This article is general information only and not personal medical advice. Smartwatch health metrics are wellness and screening tools, not diagnostic instruments. If your wearable detects an irregular heart rhythm, flags a very low VO2 max, or if you are experiencing cardiac symptoms, please consult your GP or cardiologist for personalised assessment and advice.